Silo Pharma Files 2024 Annual Report
Ticker: SILO · Form: 10-K · Filed: Mar 28, 2025 · CIK: 1514183
| Field | Detail |
|---|---|
| Company | Silo Pharma, Inc. (SILO) |
| Form Type | 10-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, filing
TL;DR
Silo Pharma filed its 10-K for FY2024. Check financials.
AI Summary
Silo Pharma, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company, formerly known as Uppercut Brands, Inc., is incorporated in Nevada and operates in the pharmaceutical preparations sector. Its principal executive offices are located at 677 N. Washington Boulevard, Sarasota, FL 34236.
Why It Matters
This filing provides a comprehensive overview of Silo Pharma's financial performance and business operations for the past fiscal year, crucial for investors and stakeholders to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual report filing and does not contain immediate, high-impact news.
Key Players & Entities
- Silo Pharma, Inc. (company) — Registrant
- December 31, 2024 (date) — Fiscal year end
- Uppercut Brands, Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- 677 N. Washington Boulevard, Sarasota, FL 34236 (address) — Principal executive offices
FAQ
What was Silo Pharma, Inc.'s former name?
Silo Pharma, Inc. was formerly known as Uppercut Brands, Inc.
In which state is Silo Pharma, Inc. incorporated?
Silo Pharma, Inc. is incorporated in Nevada.
What is the SIC code for Silo Pharma, Inc.?
The Standard Industrial Classification (SIC) code for Silo Pharma, Inc. is 2834, Pharmaceutical Preparations.
What is the filing date of this 10-K report?
This 10-K report was filed on March 28, 2025.
What is the address of Silo Pharma, Inc.'s principal executive offices?
The principal executive offices of Silo Pharma, Inc. are located at 677 N. Washington Boulevard, Sarasota, FL 34236.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 28, 2025 regarding Silo Pharma, Inc. (SILO).